Cargando…

Searching for BRCA3 by exome sequencing

Detalles Bibliográficos
Autores principales:	Makunin, I, Stark, M, Gartside, M, Chenevix-Trench, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326938/ http://dx.doi.org/10.1186/1897-4287-10-S2-A68

Ejemplares similares

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
por: Bolton, KL, et al.
Publicado: (2012)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome
por: Li, JJ, et al.
Publicado: (2012)

The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study
por: Hosein, AN, et al.
Publicado: (2012)

PW02-001 - Exome sequencing for autoinflammatory disorders
por: Boyden, SE, et al.
Publicado: (2013)

OR9-001 - Exome sequencing in monogenic Behçet-like disease
por: Zhou, Q, et al.
Publicado: (2013)

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012)

Identification of breast cancer susceptibility genes using whole exome sequencing
por: Thompson, E, et al.
Publicado: (2012)

No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
por: Campbell, Ian G, et al.
Publicado: (2004)

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
por: Martínez-Ferrandis, JI, et al.
Publicado: (2000)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study
por: Hung, J, et al.
Publicado: (2012)

Early exploration of two candidate breast cancer susceptibility genes identified by whole-exome sequencing
por: Blanc, R, et al.
Publicado: (2012)

The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
por: Sawyer, S, et al.
Publicado: (2012)

Genetic factors predisposing to bronchopulmonary dysplasia. A pilot study by exome sequencing and pathways analysis
por: Somaschini, Marco, et al.
Publicado: (2015)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

BRCA1 testing in Lithuania
por: Janavicius, Ramunas
Publicado: (2012)

BRCA2 interacting proteins
por: Vidarsson, H, et al.
Publicado: (2000)

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
por: Kote-Jarai, Z, et al.
Publicado: (2000)

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
por: Johnson, SM, et al.
Publicado: (2000)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

The Australian Ovarian Cancer Study
por: Traficante, N, et al.
Publicado: (2012)

BRCA1 mutation analysis in breast and ovarian cancer families from Greece
por: Konstantopoulou, I, et al.
Publicado: (2000)

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
por: Ghimenti, C, et al.
Publicado: (2000)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
por: Jaworska, K, et al.
Publicado: (2012)

What are the unmet support needs of women with a known BRCA1/2 mutation?
por: White, V, et al.
Publicado: (2012)

From GWAS to genome sequencing: complementary approaches to identify melanoma predisposition genes
por: MacGregor, S, et al.
Publicado: (2012)

When, how and why BRCA1 and BRCA2 genetic testing is offered to patients who do not meet standard criteria
por: Duffy, J, et al.
Publicado: (2012)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007)

Molecular characterization of BRCA1 and BRCA2 genes in breast cancer patients under 40 years-old or with familiar cancer history
por: Millan, Silvia Vidal, et al.
Publicado: (2007)

Expanded genetic analysis of a PALB2 c.3113G>A mutation carrying multiple-case breast cancer family via exome sequencing
por: Teo, ZL, et al.
Publicado: (2012)

Folic acid and cancer risk in BRCA1 carriers
por: Durda, Katarzyna, et al.
Publicado: (2012)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

Expression profiling of BRCA1 associated breast tumors
por: Berns, EMJJ, et al.
Publicado: (2000)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b66frefh12jjedjlehsttacpuc